GLP-1 side effects & safety
The most common GLP-1 side effects are gastrointestinal — nausea, vomiting, diarrhea, and constipation — usually mild to moderate and often eased by gradual dose titration. Rare but serious risks include pancreatitis and gallbladder problems, plus a boxed warning for thyroid tumors. Know the warning signs and when to call your provider.
Common gastrointestinal side effects
Because GLP-1 medications slow stomach emptying and act on the gut, most side effects are digestive. According to FDA labeling for products like Wegovy, Ozempic, Zepbound, and Mounjaro, the most frequently reported effects include:
- Nausea — the most common effect, especially early in treatment or after a dose increase
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain or discomfort
- Indigestion, burping, or feeling unusually full
- Fatigue and headache in some people
How titration reduces side effects
GLP-1 medications are started at a low dose and increased in steps over weeks or months — a process called titration. This gives the body time to adjust and is the main strategy for limiting nausea and other GI effects. Most side effects are mild to moderate and tend to lessen as the body adapts.
Simple measures can also help: eating smaller meals, stopping when full, avoiding greasy or very rich foods, and staying hydrated. If side effects are hard to tolerate, your provider may slow the titration or hold the dose — never increase, skip, or stop doses on your own without talking to your provider.
Serious risks and warnings
Boxed warning — thyroid C-cell tumors: The FDA labels for these medications carry a boxed warning (the agency's strongest) because, in rodent studies, GLP-1 and GIP/GLP-1 medications caused thyroid C-cell tumors. Whether this occurs in humans is not determined. These medications are contraindicated — meaning they should not be used — in anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Other serious but less common risks reported in FDA labeling include: pancreatitis (inflammation of the pancreas); gallbladder problems, including gallstones that may require surgery; kidney injury, often linked to dehydration from severe vomiting or diarrhea; serious allergic reactions; low blood sugar (particularly when combined with insulin or sulfonylureas); and diabetic retinopathy complications in some people with diabetes. Compounded versions are not the FDA-approved products and have not been evaluated by the FDA for safety, effectiveness, or quality.
This page is educational and is not medical advice. Discuss your full health history and all risks with a licensed provider, who decides whether a GLP-1 medication is appropriate for you.
When to call your provider
Mild, short-lived nausea or digestive upset is common early on. But contact your provider promptly — or seek emergency care — if you experience any of the following warning signs:
- Severe or persistent abdominal pain, especially pain that radiates to the back — a possible sign of pancreatitis
- Vomiting or diarrhea severe enough that you cannot keep fluids down, or signs of dehydration
- Pain in the upper-right abdomen, fever, yellowing of the skin or eyes, or clay-colored stools — possible gallbladder problems
- A lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath — possible thyroid tumor signs
- Signs of a serious allergic reaction: swelling of the face, lips, tongue, or throat, or difficulty breathing (seek emergency care)
- Symptoms of low blood sugar such as shakiness, sweating, confusion, or dizziness, particularly if you also take insulin or a sulfonylurea
- Changes in vision, if you have diabetes
How long do GLP-1 side effects last?
Most GI side effects like nausea are strongest early in treatment or right after a dose increase, and they often ease within days to weeks as the body adjusts. Gradual dose titration is the main way providers reduce them. If symptoms are severe or persistent, contact your provider.
How can I reduce nausea on a GLP-1 medication?
Eating smaller meals, stopping when full, avoiding greasy or very rich foods, and staying hydrated can help. Following your provider's titration schedule is key. Never increase or skip doses on your own to manage side effects — talk to your provider first.
Who should not take a GLP-1 medication?
These medications carry a boxed warning and are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). They are also not appropriate for people with certain other conditions. A licensed provider reviews your full history to decide if they are safe for you.
What are the signs of a serious problem I shouldn't ignore?
Seek prompt or emergency care for severe abdominal pain that may spread to the back (possible pancreatitis), upper-right belly pain with fever or yellowing skin (possible gallbladder issue), a neck lump or trouble swallowing, or swelling of the face and throat with trouble breathing (allergic reaction).
Are compounded GLP-1 medications as safe as the brand-name ones?
Compounded medications are not FDA-approved and are not the same as brand-name products like Wegovy, Ozempic, Zepbound, or Mounjaro. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality. Discuss any product with a licensed provider so you understand what you are taking.